ENTRY       N00390                      Network
NAME        EGF-EGFR-PI3K-NFKB signaling pathway
DEFINITION  EGF -> EGFR -> PI3K -> PIP3 -> AKT -> IKK -> NFKBIA -> NFKB
  EXPANDED  1950 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000) -> (1147+3551+8517) -> 4792 -> (4790+5970)
CLASS       nt06214 PI3K signaling
            nt06114 PI3K signaling (virus)
            nt06160 Human T-cell leukemia virus 1 (HTLV-1)
            nt06167 Human cytomegalovirus (HCMV)
TYPE        Reference
PATHWAY     hsa04151  PI3K-Akt signaling pathway
GENE        1950  EGF; epidermal growth factor
            1956  EGFR; epidermal growth factor receptor
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
            207  AKT1; AKT serine/threonine kinase 1
            208  AKT2; AKT serine/threonine kinase 2
            10000  AKT3; AKT serine/threonine kinase 3
            1147  CHUK; conserved helix-loop-helix ubiquitous kinase
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase subunit gamma
            4792  NFKBIA; NFKB inhibitor alpha
            4790  NFKB1; nuclear factor kappa B subunit 1
            5970  RELA; RELA proto-oncogene, NF-kB subunit
METABOLITE  C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:18721898
  AUTHORS   Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS, Workman P
  TITLE     Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises.
  JOURNAL   Curr Opin Pharmacol 8:393-412 (2008)
            DOI:10.1016/j.coph.2008.08.004
REFERENCE   PMID:25690730
  AUTHORS   Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS, Sethi G
  TITLE     NF-kappaB in cancer therapy.
  JOURNAL   Arch Toxicol 89:711-31 (2015)
            DOI:10.1007/s00204-015-1470-4
///
